Literature DB >> 7505872

High-strength pancreatic enzyme supplements and large-bowel stricture in cystic fibrosis.

P J Oades, A Bush, P S Ong, R J Brereton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7505872

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

1.  Colonic wall thickness measured by ultrasound: striking differences in patients with cystic fibrosis versus healthy controls.

Authors:  H P Haber; N Benda; G Fitzke; A Lang; M Langenberg; J Riethmüller; M Stern
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

2.  Is fibrosing colonopathy an immune mediated disease?

Authors:  J Lee; W Ip; P Durie
Journal:  Arch Dis Child       Date:  1997-07       Impact factor: 3.791

3.  In Vitro Comparison of Physical Parameters, Enzyme Activity, Acid Resistance, and pH Dissolution Characteristics of Enteric-Coated Pancreatic Enzyme Preparations: Implications for Clinical Variability and Pharmacy Substitution.

Authors:  Robert J Kuhn; Sabine Eyting; Friederike Henniges; Andreas Potthoff
Journal:  J Pediatr Pharmacol Ther       Date:  2007-04

Review 4.  Novel oral drug formulations. Their potential in modulating adverse effects.

Authors:  A T Florence; P U Jani
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

Review 5.  Adverse drug events related to dosage forms and delivery systems.

Authors:  I F Uchegbu; A T Florence
Journal:  Drug Saf       Date:  1996-01       Impact factor: 5.606

Review 6.  Nutritional management of cystic fibrosis.

Authors:  A MacDonald
Journal:  Arch Dis Child       Date:  1996-01       Impact factor: 3.791

Review 7.  Fibrosing colonopathy in cystic fibrosis.

Authors:  R L Smyth
Journal:  Arch Dis Child       Date:  1996-05       Impact factor: 3.791

8.  Ulcerative type of colitis associated with the use of high strength pancreatic enzyme supplements in cystic fibrosis.

Authors:  D S Ablin; M Ziegler
Journal:  Pediatr Radiol       Date:  1995

9.  Efficacy and Safety of a New Formulation of Pancrelipase (Ultrase MT20) in the Treatment of Malabsorption in Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

Authors:  Michael W Konstan; Theodore G Liou; Steven D Strausbaugh; Richard Ahrens; Jamshed F Kanga; Gavin R Graff; Kathryn Moffett; Susan L Millard; Samya Z Nasr; Edith Siméon; Jean Spénard; Josée Grondin
Journal:  Gastroenterol Res Pract       Date:  2010-12-08       Impact factor: 2.260

10.  Chitosan nanoencapsulated exogenous trypsin biomimics zymogen-like enzyme in fish gastrointestinal tract.

Authors:  Rakhi Kumari; Subodh Gupta; Arvind R Singh; S Ferosekhan; Dushyant C Kothari; Asim Kumar Pal; Sanjay Balkrishna Jadhao
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.